Literature DB >> 15662104

Influence of beta-adrenergic antagonists on tear secretion in children.

Elzbieta Samochowiec-Donocik1, Bronisława Koraszewska-Matuszewska.   

Abstract

The aim of the study was to compare the results of tear film volume, conjunctival and corneal state of children eyes both treated with beta-blocker and healthy ones. We have examined 40 eyes of 20 children at the age from 7 to 17 years. Group I - 20 glaucomatous eyes treated with 0.5% timolol twice daily during at least 12 months. Group II - 20 eyes of control age-matched group. Schirmer I test without anesthesia and lissamine green staining was performed to evaluate conjunctival and corneal surface. The values of Schirmer I test were: group I from 12 to 24 mm, the mean 17.06 +/- 1.78 mm and group II from 16 to 35 mm, the mean 29.3 +/- 2.67, p = 0.000004. Keratoepitheliopathy was observed in 4 eyes (20%) of group I and was rated as 3rd and 6th degree of Franck classification. In the group II, there were only single staining points classified as 1st degree noticed in 2 eyes (10%), p = 0.37. The long-term treatment with timolol causes a decrease in tear secretion in children, which can further generate keratoepiteliopathy. Therefore, we suggest application of the artificial tears in these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662104

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  3 in total

1.  Effects of short-term oral administration of propranolol on tear secretion in clinically normal dogs.

Authors:  Masoud Selk Ghaffari; Vahid Arzani; Nargess Khorami; Seyed Mehdi Rajaei
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

2.  Ocular Surface Changes in Primary Open Angle Glaucoma with Long Term Topical Anti Glaucoma Medication.

Authors:  A P Kamath; S Satyanarayana; Fea Rodrigues
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Pediatric Glaucoma: Pharmacotherapeutic Options.

Authors:  Monica Samant; Anagha Medsinge; Ken K Nischal
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.